Conference Coverage

Partial nephrectomies on rise for early-stage RCC


 

REPORTING FROM THE AUA ANNUAL MEETING


“I think that regionalization of care has ... some benefits to patients, but it comes with many challenges as well. This study really did help show that increased numbers [of procedures performed] makes you more comfortable and willing to offer partial nephrectomy,” said Dr. Cahn, of Fox Chase Cancer Center, Philadelphia.

“Volume tends to show better outcomes. But the concern is: Are you overloading systems? Are you making patients travel farther, and how does that work in terms of follow-up care?” Dr. Cahn said. He cited the example of a patient who may have to travel several hours to get surgery but then returns home and develops a postoperative complication that must be treated in a different facility. That raises issues of transfer of medical records and coordination of care.

The solution, he said, is for some of the procedures and practices common at high-volume centers to be transferred to smaller centers. “For the routine partial nephrectomy ... we need to have well-trained physicians who can offer those all over the country. I think it’s too hard in terms of feasibility to push those patients just towards certain high volume centers.”

SOURCE: AUA Annual Meeting, Abstract PD07-04.

Pages

Recommended Reading

Study sheds new light on prognostic factors in PRCC
MDedge Hematology and Oncology
Sunitinib alone not inferior to nephrectomy-sunitinib in metastatic RCC
MDedge Hematology and Oncology
Sunitinib for RCC: Side effects predictable, manageable, and reversible
MDedge Hematology and Oncology
Patients with mRCC survive longer at high-volume centers
MDedge Hematology and Oncology
PD1 mRNA may predict response to anti-PD1 monotherapy across cancer types
MDedge Hematology and Oncology
Prognostic model has clinical utility in mCRPC
MDedge Hematology and Oncology
Osteonecrosis of jaw in mRCC higher with denosumab/antiangiogenics
MDedge Hematology and Oncology
TKIs feasible and effective in Brazilian population with clear cell RCC
MDedge Hematology and Oncology
SBRT controls oligometastatic RCC in majority of patients
MDedge Hematology and Oncology
CRP levels may augur RCC prognosis
MDedge Hematology and Oncology